These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 15696143

  • 1. Chasing biotech, state by state--winners and losers.
    Wilan KH.
    Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
    [No Abstract] [Full Text] [Related]

  • 2. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A.
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract] [Full Text] [Related]

  • 3. Biotech IPOs--flop or pop?
    Jacobs T.
    Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641
    [No Abstract] [Full Text] [Related]

  • 4. The YIC factor.
    Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Benefits of biotech clusters questioned.
    Sheridan C.
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract] [Full Text] [Related]

  • 8. The importance of angels in starting a US biotech venture.
    Sohl J.
    Nat Biotechnol; 2005 Feb; 23(2):263-4. PubMed ID: 15724275
    [No Abstract] [Full Text] [Related]

  • 9. Mind the (biomedical funding) gap.
    Klausner A.
    Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. US venture capital for biotechnology.
    Dibner MD, Trull M, Howell M.
    Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144
    [No Abstract] [Full Text] [Related]

  • 13. VC funding hits high in Q1.
    Lawrence S.
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The rise of European venture capital for biotechnology.
    Howell M, Trull M, Dibner MD.
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enthusiasm cools in Q2.
    Lawrence S.
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biotech holds steady in Q4.
    Mitchell P.
    Nat Biotechnol; 2004 Feb; 22(2):135-6. PubMed ID: 14755275
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.